Paracetamol provides no benefits in fighting influenza virus

Some doctors may recommend that patients with the flu take acetaminophen, or paracetemol, to relieve their symptoms; however, a new randomized clinical trial found no benefits to the over-the-counter medication in terms of fighting the influenza virus or reducing patients' temperature or other symptoms.

The trial included adults between 18 and 65 years of age with confirmed influenza infections who were treated with the maximum recommended dose of paracetamol or placebo for five days. Participants were monitored for up to 14 days.

"We initially theorized that taking paracetamol might be harmful, as the influenza virus cannot replicate as well at higher temperatures, and by reducing a person's temperature the virus may have thrived. Fortunately this was found not be the case," said Dr. Irene Braithwaite, co-author of the Respirology study. "In this study, paracetamol was not harmful, but we also found that paracetamol was not beneficial either."

Dr. Braithwaited noted that it is difficult to make a recommendation for or against the use of paracetamol in adults with influenza or influenza-like illness based on these results. "One of the things we need to take from this, though, is that those at risk--particularly pregnant women, the very young, the old, and those with chronic medical conditions--should have the annual influenza vaccination as it confers the best protection available against the influenza virus."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?